MDXG MiMedx Group, Inc.
Healthcare$3.67+1.38%ClosedMarket Cap: $546.6M
As of 2026-05-26
Valuation
P/E (TTM)
11.81
PEG
0.81
P/B
2.21
P/S
1.38
EV/EBITDA
6.87
DCF Value
$3.82
FCF Yield
12.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
81.0%
Operating Margin
10.2%
Net Margin
7.9%
ROE
12.9%
ROA
9.9%
ROIC
10.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $59.0M | 70.6% | $-16.0M | $-10.9M | $— | — |
| Q4 null | $118.1M | 83.9% | $21.1M | $15.2M | $— | — |
| FY null | $418.6M | 82.6% | $63.9M | $48.6M | $— | — |
| Q3 null | $113.7M | 83.5% | $22.2M | $16.7M | $— | — |
| Q2 null | $98.6M | 81.1% | $12.4M | $9.6M | $— | — |
| Q1 null | $88.2M | 81.2% | $8.3M | $7.0M | $— | — |
| Q4 null | $92.9M | 81.8% | $11.1M | $7.4M | $— | — |
| FY null | $348.9M | 82.8% | $58.9M | $42.4M | $— | — |
| Q3 null | $84.1M | 81.8% | $11.2M | $8.1M | $— | — |
| Q2 null | $87.2M | 82.7% | $23.4M | $17.6M | $— | — |
| Q1 null | $84.7M | 84.4% | $13.2M | $9.3M | $— | — |
| Q4 2023 | $86.8M | 84.1% | $15.5M | $53.5M | $0.35 | — |